3 Healthcare & Biotech Stocks up over 55% past 10 days
Powered by HealthTechMovers.com
Today, our screeners were at work and below is a list of 3 Healthcare & Biotech Stocks up over 55% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com. Another great tool for charting is TradingView.com, so you might want to check that out too.
Mountain Crest Acquisition II, BTTX
Summary: Better Therapeutics Inc. is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. Better Therapeutics Inc., formerly known as Mountain Crest Acquisition Corp II, is based in SAN FRANCISCO.
| Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
| BTTX | Mountain Crest Acquisition II | Healthcare & Biotech | $1.83 | $1.86 | +101% |
TipRanks.com reports that Mountain Crest Acquisition II currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.50.
Here are 3rd party ratings for BTTX:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Nuvectis Pharma Inc. is a biopharmaceutical company. It focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. Nuvectis Pharma Inc. is based in Fort Lee, NJ.
| Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
| NVCT | Nuvectis Pharma | Healthcare & Biotech | $17.86 | $18.33 | +88% |
TipRanks.com reports that Nuvectis Pharma currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $21.00.
Here are 3rd party ratings for NVCT:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
| Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
| CMPX | Compass Therapeutics | Healthcare & Biotech | $2.3000 | $2.49 | +55% |
TipRanks.com reports that Compass Therapeutics currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $9.75.
Here are 3rd party ratings for CMPX:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com. The other great tool for charting is TradingView.com, so you might want to check that out too.
